Mona G Sarkiss

Title: Innovations in Cancer Therapy by Mona G. Sarkiss

Introduction

Mona G. Sarkiss is an accomplished inventor based in Houston, TX (US). She has made significant contributions to the field of cancer therapy through her innovative research and development of viral vectors. Her work focuses on the induction of apoptotic or cytotoxic gene expression, which has the potential to transform cancer treatment.

Latest Patents

Mona G. Sarkiss holds a patent for her invention titled "Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery." This invention relates to the use of adenoviral vectors containing pro-apoptotic genes for transforming human cells, both in vitro and in vivo. The application of this technology is particularly relevant in the context of cancer therapy, offering new avenues for treatment.

Career Highlights

Mona is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing the challenges of cancer treatment. With a focus on gene therapy, she is at the forefront of advancements in this critical area of medical research.

Collaborations

Mona G. Sarkiss has collaborated with notable colleagues, including Timothy J. McDonnell and Stephen G. Swisher. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.

Conclusion

Mona G. Sarkiss is a pioneering inventor whose work in cancer therapy through adenoviral vectors is making a significant impact. Her innovative approach and dedication to research continue to advance the field, offering hope for improved treatment options for cancer patients.